E-DRUG: ARV Policy, Adherence, and Program Management course 16-27 July 2007
Boston
--------------------------------------------------------
WHO Collaborating Center in Pharmaceutical Policy and Boston University
Seminar
Antiretroviral Program Management Issues in Low Resource Settings:
A Training Seminar for Policy Makers & Program Managers
July 16 - July 27, 2007
Boston, MA USA
Background
Funding through Global Fund, PEPFAR, and other initiatives has recently
transformed AIDS into a treatable disease in developing and transitional
countries. Resources such as ARVs and diagnostics are now available;
however, rapid scale-up of AIDS treatment programs has not occurred, in
part, due to ARV drug management issues. ARV drug management issues
include difficulties with pharmaceutical supply systems and logistics,
insufficient human resources to provide ART and barriers to ARV
adherence.
Seminar Overview
Week One (July 16-20, 2007): Drug Management Key Issues:
A description of the various national and international players involved
in ARV management will be discussed with recommendations to efficiently
coordinate efforts. Specific drug management issues to be covered
include: evidence-based selection of medications, quantification,
procurement, pricing, quality assurance, pre-qualification of suppliers
and monitoring and evaluation.
Week 2 (July 23-July 27, 2007): ARV Adherence:
An overview of adherence issues will be followed by instruction on how
to measure ARV adherence. Approaches to improve adherence to AIDS and
other chronic diseases will be presented. A field visit to an ARV
adherence clinic will allow participants an opportunity to interact with
health care practitioners (pharmacists, physicians, nurses, social
workers, nutritionists) involved in ARV adherence activities. The field
visit will include workshops with people living with HIV/AIDS (PLWHA),
allowing participants to consider the patient perspective of initiation
and adherence to ARVs.
Who Should Attend?
Policy makers, ARV Program Managers, and NGO Officials responsible for
national and local programs. Social scientists, pharmacists, and other
public health professionals interested in ARV management and adherence.
Teaching Methods
Instruction will occur in English. The format will be highly interactive
with presentations by international experts followed by facilitated
group exercises and discussion. Case studies and guided readings will be
provided and substantial preparation is required for each session. A
field visit to an ARV Adherence Clinic will be arranged. Classes will
run in the afternoons.
Faculty
Brenda Waning, Boston University School of Public Health;
Richard Laing, World Health Organization, Geneva;
Mike Montagne, Massachusetts College of Pharmacy and Health Sciences;
Libby Levison, Independent Consultant;
Lisa Hirschhorn, John Snow, Inc.
Fees
Conference costs (no academic credit): $1,350 USD includes tuition and
materials fee.
For more information and an application contact Sarah Petty at
spetty@bu.edu or by phone (+1) 617-638-5234
http://sph.bu.edu/